Synergistic botanical formulation for the treatment of herpes virus infections and related methods

Abstract

A synergistic botanical formulation and related methods for the treatment of herpes virus infections, particularly herpes simplex virus type 1 (HSV-1), are disclosed. The formulation comprises at least one botanical extract with an extracellular antiviral mechanism and at least one botanical extract with an intracellular antiviral mechanism, selected through in vitro assays to provide complementary modes of action. Extracts are prepared under conditions that selectively isolate hydrophilic or hydrophobic constituents, and are combined in proportions based on individual antiviral activity to maximize synergistic inhibition of viral replication. The formulation is standardized to measured biological activity rather than marker compounds, ensuring consistent therapeutic performance despite variability in botanical sources. When administered topically, the formulation reduces lesion healing time, increases antiviral potency compared to conventional over-the-counter treatments, and decreases the likelihood of viral resistance development. Pharmaceutical compositions, methods of preparation, and treatment protocols are also provided.

Dependencies are inferred from the claim text.